DOW
34
4
TMO
47
3
GWW
71
4
GM
68
3
EXPE
91
3
ES
31
3
AVGO
22
2
BMY
58
5
WAT
53
6
LEN
52
2
BWA
46
2
BSX
70
2
PLD
48
-5
FDX
40
4
VTR
54
5
HPQ
57
-2
BIIB
28
2
ORLY
60
7
CMS
60
2
FOXA
59
4
DOW
34
4
TMO
47
3
GWW
71
4
GM
68
3
EXPE
91
3
ES
31
3
AVGO
22
2
BMY
58
5
WAT
53
6
LEN
52
2
BWA
46
2
BSX
70
2
PLD
48
-5
FDX
40
4
VTR
54
5
HPQ
57
-2
BIIB
28
2
ORLY
60
7
CMS
60
2
FOXA
59
4
Financhill
Back

Protagonist Therapeutics Vs. Entrada Therapeutics Industry Stock Comparison

Sell
33

PTGX
Protagonist Therapeutics

Last Price:
46.45
Seasonality Move:
11.46%
Buy
58

TRDA
Entrada Therapeutics

Last Price:
18.85
Seasonality Move:
-29.61%
Sell
33
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $41.65. The Score for PTGX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $18.05. The Score for TRDA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $41.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $18.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 41.01 Sell
Chaikin Money Flow: -281616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 50.91 Buy
Chaikin Money Flow: 10625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.17 Buy
20-day SMA: 44.7 Sell
50-day SMA: 45.23 Sell
200-day SMA: 35.68 Buy
8-day EMA: 41.66 Sell
20-day EMA: 43.5 Sell
50-day EMA: 43.92 Sell
200-day EMA: 36.78 Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.48 Sell
20-day SMA: 18.27 Sell
50-day SMA: 16.93 Buy
200-day SMA: 15.19 Buy
8-day EMA: 18.24 Sell
20-day EMA: 18.15 Sell
50-day EMA: 17.37 Buy
200-day EMA: 15.84 Buy

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):